Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Newsletter
Environmental Politics, Internet Gambling and Drug Imports
Regnery Publishing releases the new book The Really Inconvenient Truths: Seven Environmental Catastrophes Liberals Don't Want You to Know About--Because They Helped Cause Them. An…
Op-Eds
Anatomy of a Chemical Murder
Wal-Mart announced last week that it would stop selling baby bottles made with the chemical bisphenol A, or BPA.
News Release
Are Imports the Solution to High Drug Prices?
With the high cost of pharmaceutical drugs playing a central role in the national debate over health care, many policymakers have endorsed the idea…
Newsletter
Custody Disputes, Food Shortages and Taxi Cab Fares
Over 400 children seized from a polygamous sect in Texas are dispersed to group homes and shelters across the state. Zimbabwe, confronted with high food…
Study
Drug Reimportation’s Dangerous Allure
A Misguided Cost-Control Measure Guaranteed to Harm Patient Care…
Newsletter
Sarbanes-Oxley, Cancer Drugs and Discrimination Law
The National Law Journal warns that penalties in the Sarbanes-Oxley accounting rules for public companies can extend to individuals and private entities. Drug maker Cephalon…